First Time Loading...
N

Nichi-Iko Pharmaceutical Co Ltd
TSE:4541

Watchlist Manager
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Watchlist
Price: 0.0001 JPY Market Closed
Updated: Apr 29, 2024

Nichi-Iko Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nichi-Iko Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Revenue
¥179.1B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Revenue
¥4.2T
CAGR 3-Years
9%
CAGR 5-Years
19%
CAGR 10-Years
10%
Daiichi Sankyo Co Ltd
TSE:4568
Revenue
¥1.5T
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
4%
Otsuka Holdings Co Ltd
TSE:4578
Revenue
¥2T
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Revenue
¥1.1T
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Revenue
¥1.9T
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
6%

See Also

What is Nichi-Iko Pharmaceutical Co Ltd's Revenue?
Revenue
179.1B JPY

Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Revenue amounts to 179.1B JPY.

What is Nichi-Iko Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
4%

Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Nichi-Iko Pharmaceutical Co Ltd have been 2% over the past three years , 4% over the past five years .